Skip to main content

Table 1 Properties of breast cancer cell lines used in this study a

From: Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

Cell lines

Subtype

ER

PR

Her2

p53

TGFβ effects

Other properties

MCF-7

Luminal

+

+

 

+/− Wild type

Growth inhibition

 

MDA-MB-231

Basal B

 

+/+ Mutated

Migration, invasion

 

SCP2

Basal B

 

Not tested

Migration, invasion

Metastasize to bone

BT-549

Basal B

 

+/+ Mutated

Migration, invasion

 

SUM-149PT

Basal B

 

+ As per mRNA

Growth inhibition

 

SUM-159PT

Basal B

 

+ As per mRNA

Invasion

 

SK-BR-3

Luminal

Overexpress

Mutated

  

MCF-7

Luminal

+

+

 

+/− Wild type

Growth inhibition

 

MDA-MB-231

Basal B

 

+/+ Mutated

Migration, invasion

 

SCP2

Basal B

 

Not tested

Migration, invasion

Metastasize to bone

BT-549

Basal B

 

+/+ Mutated

Migration, invasion

 

SUM-149PT

Basal B

 

+ As per mRNA

Growth inhibition

 

SUM-159PT

Basal B

 

+ As per mRNA

Invasion

 

SK-BR-3

Luminal

Overexpress

Mutated

  
  1. aER, Estrogen receptor; Her2, Human epidermal growth factor receptor 2; PR, Progesterone receptor; TGFβ, Transforming growth factor β.